The road to Aduhelm: What one ex-FDA adviser called 'probably the worst drug approval decision in recent US history' for an Alzheimer's treatment CNNNew Alzheimer's drug is for those with mild cognitive impairment. But who has that disorder? The Washington PostView Full Coverage on Google News